diclofenac has been researched along with Esophageal Squamous Cell Carcinoma in 1 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
Esophageal Squamous Cell Carcinoma: A carcinoma that originates usually from cells on the surface of the middle and lower third of the ESOPHAGUS. Tumor cells exhibit typical squamous morphology and form large polypoid lesions. Mutations in RNF6, LZTS1, TGFBR2, DEC1, and WWOX1 genes are associated with this cancer.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kabir, MF | 1 |
| Jackson, JL | 1 |
| Fuller, AD | 1 |
| Gathuka, L | 1 |
| Karami, AL | 1 |
| Conde, DG | 1 |
| Klochkova, A | 1 |
| Mu, A | 1 |
| Cai, KQ | 1 |
| Klein-Szanto, AJ | 1 |
| Muir, AB | 1 |
| Whelan, KA | 1 |
1 other study available for diclofenac and Esophageal Squamous Cell Carcinoma
| Article | Year |
|---|---|
Diclofenac exhibits cytotoxic activity associated with metabolic alterations and p53 induction in ESCC cell lines and decreases ESCC tumor burden in vivo.
Topics: Antineoplastic Agents; Apoptosis; Cell Line; Cell Line, Tumor; Cell Proliferation; Diclofenac; Esoph | 2023 |